Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 14,978 shares at $42.82 ($641K) on 2025-01-07, disclosed to the SEC on 2025-01-08.
Open-market sale of $641k MIRM by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.82 | 7,489 | $321K | 50.0% |
| 2 | $42.82 | 7,489 | $321K | 50.0% |
| Total | $42.82 avg | 14,978 | $641K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |